Genomic-transcriptomic evolution in lung cancer and metastasis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2023
Historique:
received: 21 10 2021
accepted: 04 01 2023
medline: 21 4 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Intratumour heterogeneity (ITH) fuels lung cancer evolution, which leads to immune evasion and resistance to therapy

Identifiants

pubmed: 37046093
doi: 10.1038/s41586-023-05706-4
pii: 10.1038/s41586-023-05706-4
pmc: PMC10115639
doi:

Substances chimiques

APOBEC3A protein, human EC 3.5.4.5
ADAR protein, human EC 3.5.4.37

Banques de données

ClinicalTrials.gov
['NCT01888601']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-552

Subventions

Organisme : Cancer Research UK
ID : CTRNBC-2022/100001
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L016311/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 21999
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24956
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 17786
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2008
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W025051/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V033077/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2041
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29569
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 30025
Pays : United Kingdom

Investigateurs

Nicholas McGranahan (N)
Charles Swanton (C)
Maise Al Bakir (MA)
Emilia L Lim (EL)
Alexander M Frankell (AM)
Kevin Litchfield (K)
Nicolai J Birkbak (NJ)
Peter Van Loo (P)
Jason F Lester (JF)
Amrita Bajaj (A)
Apostolos Nakas (A)
Azmina Sodha-Ramdeen (A)
Keng Ang (K)
Mohamad Tufail (M)
Mohammed Fiyaz Chowdhry (MF)
Molly Scotland (M)
Rebecca Boyles (R)
Sridhar Rathinam (S)
Claire Wilson (C)
Domenic Marrone (D)
Sean Dulloo (S)
Dean A Fennell (DA)
Gurdeep Matharu (G)
Jacqui A Shaw (JA)
Joan Riley (J)
Lindsay Primrose (L)
Ekaterini Boleti (E)
Heather Cheyne (H)
Mohammed Khalil (M)
Shirley Richardson (S)
Tracey Cruickshank (T)
Gillian Price (G)
Keith M Kerr (KM)
Sarah Benafif (S)
Kayleigh Gilbert (K)
Babu Naidu (B)
Akshay J Patel (AJ)
Aya Osman (A)
Christer Lacson (C)
Gerald Langman (G)
Helen Shackleford (H)
Madava Djearaman (M)
Salma Kadiri (S)
Gary Middleton (G)
Angela Leek (A)
Jack Davies Hodgkinson (JD)
Nicola Totten (N)
Angeles Montero (A)
Elaine Smith (E)
Eustace Fontaine (E)
Felice Granato (F)
Helen Doran (H)
Juliette Novasio (J)
Kendadai Rammohan (K)
Leena Joseph (L)
Paul Bishop (P)
Rajesh Shah (R)
Stuart Moss (S)
Vijay Joshi (V)
Philip Crosbie (P)
Fabio Gomes (F)
Kate Brown (K)
Mathew Carter (M)
Anshuman Chaturvedi (A)
Lynsey Priest (L)
Pedro Oliveira (P)
Colin R Lindsay (CR)
Fiona H Blackhall (FH)
Matthew G Krebs (MG)
Yvonne Summers (Y)
Alexandra Clipson (A)
Jonathan Tugwood (J)
Alastair Kerr (A)
Dominic G Rothwell (DG)
Elaine Kilgour (E)
Caroline Dive (C)
Hugo J W L Aerts (HJWL)
Roland F Schwarz (RF)
Tom L Kaufmann (TL)
Zoltan Szallasi (Z)
Judit Kisistok (J)
Mateo Sokac (M)
Miklos Diossy (M)
Abigail Bunkum (A)
Aengus Stewart (A)
Alastair Magness (A)
Angeliki Karamani (A)
Benny Chain (B)
Brittany B Campbell (BB)
Chris Bailey (C)
Christopher Abbosh (C)
Clare E Weeden (CE)
Claudia Lee (C)
Corentin Richard (C)
Crispin T Hiley (CT)
David R Pearce (DR)
Despoina Karagianni (D)
Dhruva Biswas (D)
Dina Levi (D)
Elena Hoxha (E)
Emma Nye (E)
Eva Grönroos (E)
Felip Gálvez-Cancino (F)
Francisco Gimeno-Valiente (F)
George Kassiotis (G)
Georgia Stavrou (G)
Gerasimos Mastrokalos (G)
Haoran Zhai (H)
Helen L Lowe (HL)
Ignacio Garcia Matos (IG)
Jacki Goldman (J)
James L Reading (JL)
Javier Herrero (J)
Jayant K Rane (JK)
Jerome Nicod (J)
Jie Min Lam (JM)
John A Hartley (JA)
Karl S Peggs (KS)
Katey S S Enfield (KSS)
Kayalvizhi Selvaraju (K)
Kevin W Ng (KW)
Kezhong Chen (K)
Krijn Dijkstra (K)
Kristiana Grigoriadis (K)
Krupa Thakkar (K)
Leah Ensell (L)
Mansi Shah (M)
Marcos Vasquez Duran (MV)
Maria Litovchenko (M)
Mariana Werner Sunderland (MW)
Michelle Leung (M)
Mickael Escudero (M)
Mihaela Angelova (M)
Monica Sivakumar (M)
Olga Chervova (O)
Olivia Lucas (O)
Othman Al-Sawaf (O)
Philip Hobson (P)
Piotr Pawlik (P)
Richard Kevin Stone (RK)
Robert Bentham (R)
Robert E Hynds (RE)
Roberto Vendramin (R)
Sadegh Saghafinia (S)
Saioa López (S)
Samuel Gamble (S)
Seng Kuong Anakin Ung (SKA)
Sergio A Quezada (SA)
Sharon Vanloo (S)
Simone Zaccaria (S)
Sonya Hessey (S)
Stefan Boeing (S)
Supreet Kaur Bola (SK)
Tamara Denner (T)
Teresa Marafioti (T)
Thanos P Mourikis (TP)
Victoria Spanswick (V)
Vittorio Barbè (V)
Wei-Ting Lu (WT)
William Hill (W)
Wing Kin Liu (WK)
Yin Wu (Y)
Yutaka Naito (Y)
Zoe Ramsden (Z)
Catarina Veiga (C)
Gary Royle (G)
Charles-Antoine Collins-Fekete (CA)
Francesco Fraioli (F)
Paul Ashford (P)
Tristan Clark (T)
Martin D Forster (MD)
Siow Ming Lee (SM)
Elaine Borg (E)
Mary Falzon (M)
Dionysis Papadatos-Pastos (D)
James Wilson (J)
Tanya Ahmad (T)
Alexander James Procter (AJ)
Asia Ahmed (A)
Magali N Taylor (MN)
Arjun Nair (A)
David Lawrence (D)
Davide Patrini (D)
Neal Navani (N)
Ricky M Thakrar (RM)
Sam M Janes (SM)
Emilie Martinoni Hoogenboom (EM)
Fleur Monk (F)
James W Holding (JW)
Junaid Choudhary (J)
Kunal Bhakhri (K)
Marco Scarci (M)
Martin Hayward (M)
Nikolaos Panagiotopoulos (N)
Pat Gorman (P)
Reena Khiroya (R)
Robert C M Stephens (RCM)
Yien Ning Sophia Wong (YNS)
Steve Bandula (S)
Abigail Sharp (A)
Sean Smith (S)
Nicole Gower (N)
Harjot Kaur Dhanda (HK)
Kitty Chan (K)
Camilla Pilotti (C)
Rachel Leslie (R)
Anca Grapa (A)
Hanyun Zhang (H)
Khalid AbdulJabbar (K)
Xiaoxi Pan (X)
Yinyin Yuan (Y)
David Chuter (D)
Mairead MacKenzie (M)
Serena Chee (S)
Aiman Alzetani (A)
Judith Cave (J)
Lydia Scarlett (L)
Jennifer Richards (J)
Papawadee Ingram (P)
Silvia Austin (S)
Eric Lim (E)
Paulo De Sousa (P)
Simon Jordan (S)
Alexandra Rice (A)
Hilgardt Raubenheimer (H)
Harshil Bhayani (H)
Lyn Ambrose (L)
Anand Devaraj (A)
Hema Chavan (H)
Sofina Begum (S)
Silviu I Buderi (SI)
Daniel Kaniu (D)
Mpho Malima (M)
Sarah Booth (S)
Andrew G Nicholson (AG)
Nadia Fernandes (N)
Pratibha Shah (P)
Chiara Proli (C)
Madeleine Hewish (M)
Sarah Danson (S)
Michael J Shackcloth (MJ)
Lily Robinson (L)
Peter Russell (P)
Kevin G Blyth (KG)
Craig Dick (C)
John Le Quesne (J)
Alan Kirk (A)
Mo Asif (M)
Rocco Bilancia (R)
Nikos Kostoulas (N)
Mathew Thomas (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Black, J. R. M. & McGranahan, N. Genetic and non-genetic clonal diversity in cancer evolution. Nat. Rev. Cancer 21, 379–392 (2021).
pubmed: 33727690 doi: 10.1038/s41568-021-00336-2
Bailey, C. et al. Tracking cancer evolution through the disease course. Cancer Discov. 11, 916–932 (2021).
pubmed: 33811124 pmcid: 7611362 doi: 10.1158/2159-8290.CD-20-1559
Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112 doi: 10.1056/NEJMoa1616288
PCAWG Transcriptome Core Group et al. Genomic basis for RNA alterations in cancer. Nature 578, 129–136 (2020).
doi: 10.1038/s41586-020-1970-0
Marjanovic, N. D. et al. Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell 38, 229–246.e13 (2020).
pubmed: 32707077 pmcid: 7745838 doi: 10.1016/j.ccell.2020.06.012
Al Bakir, M. et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature https://doi.org/10.1038/s41586-023-05729-x (2023).
Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature https://doi.org/10.1038/s41586-023-05783-5 (2023).
Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479–485 (2019).
pubmed: 30894752 pmcid: 6954100 doi: 10.1038/s41586-019-1032-7
Travis, W. D. et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243–1260 (2015).
pubmed: 26291008 doi: 10.1097/JTO.0000000000000630
Lam, V. K. et al. Targeted tissue and cell-free tumor DNA sequencing of advanced lung squamous-cell carcinoma reveals clinically significant prevalence of actionable alterations. Clin. Lung Cancer 20, 30–36.e3 (2019).
pubmed: 30279110 doi: 10.1016/j.cllc.2018.08.020
East, P. et al. Oncogenic RAS activity predicts response to chemotherapy and outcome in lung adenocarcinoma. Nat. Commun. 13, 5632 (2022).
Dogan, S. et al. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin. Cancer Res. 18, 6169–6177 (2012).
pubmed: 23014527 pmcid: 3500422 doi: 10.1158/1078-0432.CCR-11-3265
Buettner, R. Invasive mucinous adenocarcinoma: genetic insights into a lung cancer entity with distinct clinical behavior and genomic features. Mod. Pathol. 35, 138–139 (2022).
pubmed: 34795416 doi: 10.1038/s41379-021-00945-0
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Cao, S. et al. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. Nat. Biotechnol. 40, 1624–1633 (2022).
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041.e21 (2017).
pubmed: 29056346 pmcid: 5720395 doi: 10.1016/j.cell.2017.09.042
Biswas, D. et al. A clonal expression biomarker associates with lung cancer mortality. Nat. Med. 25, 1540–1548 (2019).
pubmed: 31591602 pmcid: 6984959 doi: 10.1038/s41591-019-0595-z
Cowley, G.S. et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. Data 1, 140035 (2014).
pubmed: 25984343 pmcid: 4432652 doi: 10.1038/sdata.2014.35
Castel, S. E., Levy-Moonshine, A., Mohammadi, P., Banks, E. & Lappalainen, T. Tools and best practices for data processing in allelic expression analysis. Genome Biol. 16, 195 (2015).
pubmed: 26381377 pmcid: 4574606 doi: 10.1186/s13059-015-0762-6
Baran, Y. et al. The landscape of genomic imprinting across diverse adult human tissues. Genome Res. 25, 927–936 (2015).
pubmed: 25953952 pmcid: 4484390 doi: 10.1101/gr.192278.115
Larose Cadieux, E. et al. Copy number-aware deconvolution of tumor-normal DNA methylation profiles. Preprint at bioRxiv https://doi.org/10.1101/2020.11.03.366252 (2020).
Feinberg, A. P., Koldobskiy, M. A. & Göndör, A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet. 17, 284–299 (2016).
pubmed: 26972587 pmcid: 4888057 doi: 10.1038/nrg.2016.13
Zhou, Y. et al. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma. Aging 12, 25189–25206 (2020).
pubmed: 33223508 pmcid: 7803529 doi: 10.18632/aging.104120
Ho, T. H. et al. High-resolution profiling of histone H3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene 35, 1565–1574 (2016).
pubmed: 26073078 doi: 10.1038/onc.2015.221
Chen, K. et al. Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell 170, 492–506.e14 (2017).
pubmed: 28753426 doi: 10.1016/j.cell.2017.06.042
Bazak, L. et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 24, 365–376 (2014).
pubmed: 24347612 pmcid: 3941102 doi: 10.1101/gr.164749.113
Picardi, E., D’Erchia, A. M., Lo Giudice, C. & Pesole, G. REDIportal: a comprehensive database of A-to-I RNA editing events in humans. Nucleic Acids Res. 45, D750–D757 (2017).
pubmed: 27587585 doi: 10.1093/nar/gkw767
Sharma, S., Patnaik, S. K., Taggart, R. T. & Baysal, B. E. The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme. Sci. Rep. 6, 39100 (2016).
pubmed: 27974822 pmcid: 5156925 doi: 10.1038/srep39100
Teh, Y. W., Jordan, M. I., Beal, M. J. & Blei, D. M. Hierarchical dirichlet processes. J. Am. Stat. Assoc. 101, 1566–1581 (2006).
doi: 10.1198/016214506000000302
Sharma, S. & Baysal, B. E. Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G. PeerJ 5, e4136 (2017).
pubmed: 29230368 pmcid: 5723131 doi: 10.7717/peerj.4136
Sharma, S. et al. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages. Nat. Commun. 6, 6881 (2015).
pubmed: 25898173 doi: 10.1038/ncomms7881
Mehdipour, P. et al. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Nature 588, 169–173 (2020).
pubmed: 33087935 doi: 10.1038/s41586-020-2844-1
Sammut, S.-J. et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature 601, 623–629 (2022).
pubmed: 34875674 doi: 10.1038/s41586-021-04278-5
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018 pmcid: 7054213 doi: 10.1038/s41586-020-1943-3
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 23945592 pmcid: 3776390 doi: 10.1038/nature12477
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006).
pubmed: 16921376 doi: 10.1038/ng1861
Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015).
pubmed: 26099045 pmcid: 4500826 doi: 10.1038/nm.3886
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494 pmcid: 7611706 doi: 10.1038/s41586-020-2698-6
Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525–530 (2015).
pubmed: 26466571 pmcid: 4815041 doi: 10.1038/nature15395
López, S. et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat. Genet. 52, 283–293 (2020).
pubmed: 32139907 pmcid: 7116784 doi: 10.1038/s41588-020-0584-7
LaFave, L. M. et al. Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma. Cancer Cell 38, 212–228.e13 (2020).
pubmed: 32707078 pmcid: 7641015 doi: 10.1016/j.ccell.2020.06.006
Xie, Y. et al. SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes. Nat. Cancer 3, 188–202 (2022).
pubmed: 35115713 pmcid: 8885846 doi: 10.1038/s43018-021-00316-3
Outchkourov, N. S. et al. Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep. 3, 1071–1079 (2013).
Sungalee, S. et al. Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci. Nat. Genet. 53, 650–662 (2021).
pubmed: 33972799 doi: 10.1038/s41588-021-00842-x
Li, Q. et al. RNA editing underlies genetic risk of common inflammatory diseases. Nature 608, 569–577 (2022).
pubmed: 35922514 pmcid: 9790998 doi: 10.1038/s41586-022-05052-x
Venkatesan, S. et al. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution. Cancer Discov. 11, 2456–2473 (2021).
pubmed: 33947663 pmcid: 8487921 doi: 10.1158/2159-8290.CD-20-0725
Jalili, P. et al. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots. Nat. Commun. 11, 2971 (2020).
pubmed: 32532990 pmcid: 7293259 doi: 10.1038/s41467-020-16802-8
Petljak, M. et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature 607, 799–807 (2022).
pubmed: 35859169 pmcid: 9329121 doi: 10.1038/s41586-022-04972-y
Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature https://doi.org/10.1038/s41586-023-05776-4 (2023).
Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910–16915 (2010).
pubmed: 20837533 pmcid: 2947907 doi: 10.1073/pnas.1009843107
Andrews, S. et al. FastQC v0.11.2 (Babraham Bioinformatics, 2010).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.J 17, 10–12 (2011).
doi: 10.14806/ej.17.1.200
Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics 27, 1571–1572 (2011).
pubmed: 21493656 pmcid: 3102221 doi: 10.1093/bioinformatics/btr167
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
McKenna, A. et al. The Genome Analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Hartley, S. W. & Mullikin, J. C. QoRTs: a comprehensive toolset for quality control and data processing of RNA-seq experiments. BMC Bioinformatics 16, 224 (2015).
pubmed: 26187896 pmcid: 4506620 doi: 10.1186/s12859-015-0670-5
Pedersen, B. S. et al. Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome Med. 12, 62 (2020).
pubmed: 32664994 pmcid: 7362544 doi: 10.1186/s13073-020-00761-2
Wingett, S. W. & Andrews, S. FastQ Screen: A tool for multi-genome mapping and quality control. F1000Res. 7, 1338 (2018).
Ewels, P., Magnusson, M., Lundin, S. & Käller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016).
pubmed: 27312411 pmcid: 5039924 doi: 10.1093/bioinformatics/btw354
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
pubmed: 21816040 pmcid: 3163565 doi: 10.1186/1471-2105-12-323
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Di Tommaso, P. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35, 316–319 (2017).
pubmed: 28398311 doi: 10.1038/nbt.3820
Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. https://doi.org/10.18637/jss.v082.i13 (2017).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (Springer International Publishing, 2016).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Rizzo, M. L. & Szekely, G. J. energy: E-Statistics: multivariate inference via the energy of data. R package version 1.7-0 (2017).
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at arXiv https://doi.org/10.48550/arXiv.1802.03426 (2018).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289–300 (1995).
Fox, J. & Weisberg, S. An R Companion to Applied Regression (SAGE Publications, 2018).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308 doi: 10.1093/bioinformatics/btp616
Sergushichev, A. A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. Preprint at bioRxiv https://doi.org/10.1101/060012 (2016).
Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).
pubmed: 31249361 pmcid: 6597582 doi: 10.1038/s41598-019-45839-z
Skelly, D. A., Johansson, M., Madeoy, J., Wakefield, J. & Akey, J. M. A powerful and flexible statistical framework for testing hypotheses of allele-specific gene expression from RNA-seq data. Genome Res. 21, 1728–1737 (2011).
pubmed: 21873452 pmcid: 3202289 doi: 10.1101/gr.119784.110
Yee, T. W., Stoklosa, J. & Huggins, R. M. The VGAM package for capture-recapture data using the conditional likelihood. J. Stat. Softw. 65, 1–33 (2015).
doi: 10.18637/jss.v065.i05
Forbes, S. A. et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids. Res. 43, D805–D811 (2015).
pubmed: 25355519 doi: 10.1093/nar/gku1075
Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).
pubmed: 24390350 pmcid: 4048962 doi: 10.1038/nature12912
Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).
doi: 10.1038/nature11404
Collisson, E. et al. Comprehensive molecular profiling of lung adenocarcinoma: the Cancer Genome Atlas Research Network. Nature 511, 543–550 (2014).
doi: 10.1038/nature13385
Campbell, J. D. et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48, 607–616 (2016).
pubmed: 27158780 pmcid: 4884143 doi: 10.1038/ng.3564
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
pubmed: 19561590 doi: 10.1038/nprot.2009.86
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 7, Unit 7.20 (2013).
Schwarz, J. M., Rödelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
pubmed: 20676075 doi: 10.1038/nmeth0810-575
Shen, H. F. et al. The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis. Adv. Sci. 8, 2004635 (2021).
Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503–508 (2019).
pubmed: 31068700 pmcid: 6697103 doi: 10.1038/s41586-019-1186-3
Zhou, B. et al. Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2. Nucleic Acids Res. 47, 3846–3861 (2019).
pubmed: 30864654 pmcid: 6486628 doi: 10.1093/nar/gkz169
Benjamin, D. et al. Calling somatic SNVs and indels with Mutect2. Preprint at bioRxiv https://doi.org/10.1101/861054 (2019).
Tange, O. GNU Parallel 2018. Zenodo https://doi.org/10.5281/zenodo.1146014 (2018).
Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).
pubmed: 33590861 pmcid: 7931819 doi: 10.1093/gigascience/giab008
Khanna, A. et al. Bam-readcount–rapid generation of basepair-resolution sequence metrics. Preprint at https://arxiv.org/abs/2107.12817 (2021).
Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112–121 (2020).
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).
pubmed: 26899170 pmcid: 4762164 doi: 10.1186/s13059-016-0893-4
Lawrence, M. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9, e1003118 (2013).
pubmed: 23950696 pmcid: 3738458 doi: 10.1371/journal.pcbi.1003118
Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970–976 (2013).
pubmed: 23852170 pmcid: 3789062 doi: 10.1038/ng.2702
Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371–385.e18 (2018).
pubmed: 29625053 pmcid: 6029450 doi: 10.1016/j.cell.2018.02.060
Karasaki, T. et al. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nat. Med. https://doi.org/10.1038/s41591-023-02230-w (2023).
Merino, D. M. et al. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. J. Immunother. Cancer 8, e000147 (2020).
pubmed: 32217756 pmcid: 7174078 doi: 10.1136/jitc-2019-000147
Bentham, R. et al. Using DNA sequencing data to quantify T cell fraction and therapy response. Nature 597, 555–560 (2021).
pubmed: 34497419 doi: 10.1038/s41586-021-03894-5
Caswell, D. R. & Swanton, C. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med. 15, 133 (2017).
pubmed: 28716075 pmcid: 5514532 doi: 10.1186/s12916-017-0900-y
Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc. 4, 1184–1191 (2009).
pubmed: 19617889 pmcid: 3159387 doi: 10.1038/nprot.2009.97
Danaher, P. et al. Gene expression markers of tumor infiltrating leukocytes. J. Immunother. Cancer 5, 18 (2017).
pubmed: 28239471 pmcid: 5319024 doi: 10.1186/s40425-017-0215-8
Han, L. et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 28, 515–528 (2015).
pubmed: 26439496 pmcid: 4605878 doi: 10.1016/j.ccell.2015.08.013
Zhang, M. et al. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat. Commun. 9, 3919 (2018).
pubmed: 30254248 pmcid: 6156571 doi: 10.1038/s41467-018-06405-9
Chen, L. et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 19, 209–216 (2013).
pubmed: 23291631 pmcid: 3783260 doi: 10.1038/nm.3043
Abadi, M. et al. TensorFlow: large-scale machine learning on heterogeneous distributed systems. Preprint at arXiv https://doi.org/10.48550/arXiv.1603.04467 (2016).
Lemaître, G., Nogueira, F. & Aridas, C. K. Imbalanced-learn: a Python toolbox to tackle the curse of imbalanced datasets in machine learning. J. Mach. Learn. Res. 18, 559–563 (2017).
McKinney, W. Data structures for statistical computing in python. In Proc. 9th Python in Science Conf. (eds van der Walt, S. & Millman, J.) 51–56 (SciPy, 2010).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).

Auteurs

Carlos Martínez-Ruiz (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

James R M Black (JRM)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Clare Puttick (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Mark S Hill (MS)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Jonas Demeulemeester (J)

Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
Integrative Cancer Genomics Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium.
VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.

Elizabeth Larose Cadieux (E)

Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
Medical Genomics, University College London Cancer Institute, London, UK.

Kerstin Thol (K)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Thomas P Jones (TP)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Selvaraju Veeriah (S)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Cristina Naceur-Lombardelli (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Antonia Toncheva (A)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Paulina Prymas (P)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Andrew Rowan (A)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Sophia Ward (S)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Laura Cubitt (L)

Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Foteini Athanasopoulou (F)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Advanced Sequencing Facility, The Francis Crick Institute, London, UK.

Oriol Pich (O)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Takahiro Karasaki (T)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.

David A Moore (DA)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Department of Cellular Pathology, University College London Hospitals, London, UK.

Roberto Salgado (R)

Department of Pathology, ZAS Hospitals, Antwerp, Belgium.
Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Emma Colliver (E)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Carla Castignani (C)

Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
Medical Genomics, University College London Cancer Institute, London, UK.

Michelle Dietzen (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Ariana Huebner (A)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Maise Al Bakir (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Miljana Tanić (M)

Medical Genomics, University College London Cancer Institute, London, UK.
Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.

Thomas B K Watkins (TBK)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Emilia L Lim (EL)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Ali M Al-Rashed (AM)

Centre for Nephrology, Division of Medicine, University College London, London, UK.

Danny Lang (D)

Scientific Computing STP, Francis Crick Institute, London, UK.

James Clements (J)

Scientific Computing STP, Francis Crick Institute, London, UK.

Daniel E Cook (DE)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Rachel Rosenthal (R)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Gareth A Wilson (GA)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Alexander M Frankell (AM)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.

Sophie de Carné Trécesson (S)

Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.

Philip East (P)

Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.

Nnennaya Kanu (N)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Kevin Litchfield (K)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK.

Nicolai J Birkbak (NJ)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.

Allan Hackshaw (A)

Cancer Research UK & UCL Cancer Trials Centre, London, UK.

Stephan Beck (S)

Medical Genomics, University College London Cancer Institute, London, UK.

Peter Van Loo (P)

Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mariam Jamal-Hanjani (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
Department of Medical Oncology, University College London Hospitals, London, UK.

Charles Swanton (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.
Department of Medical Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.

Nicholas McGranahan (N)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH